Therapy Area topics

Cardiovascular

Vantage logo

The lowdown on high blood pressure

After Idorsia’s tease in resistant hypertension, data will soon emerge on other advanced assets, including long-acting RNA-based approaches.

Central Nervous System

Diabetes

Vantage logo

ADA 2022 – Move over Mounjaro?

Lilly believes it has two promising new molecules for diabetes and obesity. But which to choose – and might toxicity yet scupper one or both?

Digital Health

Oncology

Respiratory

Various

Vantage logo
Independent, data-driven daily news and analysis on pharma, biotech and medtech.